Approval · Notice of Compliance 31382 · 2023
ADTRALZA: Notice of Compliance 31382
Issued August 4, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31382
- Date
- August 4, 2023
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation: pre-filled pen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADTRALZA | 02540193 | Marketed |
Medicinal ingredients
- TRALOKINUMAB 300 MG per 2ML